Personalized Prevention: How MSK’s RISE Program Uses Genetics to Redefine Risk

At the 2025 MSK Direct Benefits Leaders’ Summit, Advanced Practice Provider Chakia Faniel discusses MSK’s RISE Program—a unique initiative helping individuals at high risk for breast cancer stay up to date with surveillance, understand prevention and risk-reduction options, and learn about ongoing research tailored to the high-risk community.